Background Organ transplant is the preferred treatment for end-stage organ disease, yet the
majority of patients with end-stage organ disease are never placed on the transplant waiting …

Abstract Background In the United States (US), barriers in access to later steps in the kidney
transplantation process (ie waitlisting) have been well documented. Barriers in access to …

Importance Living donor kidney transplant (LDKT) is the ideal treatment for end-stage kidney
disease, but racial disparities in LDKT have increased over the last 2 decades. Recipient …

Introduction Men (vs. women) are more likely to be waitlisted or receive a kidney transplant.
Whether gender disparities exist in earlier transplant steps (ie, referral) and whether age …

Kidney disease continues to manifest stark racial inequities in the United States, revealing
the entrenchment of racism and bias within multiple facets of society, including in our …

Collection of national surveillance data on early transplant steps, as well as routinely
captured data on upstream social determinants of health, including the measurement of …

Transplant referral and evaluation are critical steps to waitlisting yet remain an elusive part
of the transplant process. Despite calls for more data collection on pre-waitlisting steps …

Stark racial disparities in access to and receipt of kidney transplantation, especially living
donor and pre-emptive transplantation, have persisted despite decades of investigation and …

Importance It is unclear whether center-level factors are associated with racial equity in
living donor kidney transplant (LDKT). Objective To evaluate center-level factors and racial …

Transplantation is a life-saving medical intervention that unfortunately is constrained by
scarcity of available organs. An ideal system for allocating organs should seek to achieve …